By Jacquelyn Gray
Researchers have manufactured a peptide aimed to block modified proteins associated with Alzheimer’s disease, Parkinson’s disease, heart disease, Type 2 diabetes, Lou Gehrig’s disease, and other conditions.
By Jacquelyn Gray
A team of researchers may have identified specific risk factors explaining the association between bipolar disorder and substance abuse among teens.
By Jeannette Wick
Patients diagnosed with thyroid disease often use it as an explanation or excuse for neuropsychiatric symptoms; this is a form of “labeling effect.”
By Rachel Lutz
The cannabis-based multiple sclerosis drug Sativex has been recommended for use in Wales, making it the first in the United Kingdom to do so. The drug awaits final approval from the government.
The association between obesity and subsequent dementia varies with the age at which obesity is first recorded, according to a study published online Aug. 20 in the Postgraduate Medical Journal.
Minor infections appear to have a strong, but short-lived, effect on pediatric stroke risk, according to a study published online Aug. 20 in Neurology.
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
For preadolescent children, white matter structure varies with fitness level, according to a study published online Aug. 19 in the Frontiers of Neuroscience.
Physicians and health care providers must be aware of their potential liability when ordering screening tests, according to an article published July 24 in Medical Economics.
From 1999 through 2011 there were considerable declines in hospitalizations for acute cardiovascular disease and stroke, outpacing those of other conditions, according to a study published online Aug. 18 in Circulation.